Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarction.
The aim of the study was to determine whether the presence of angiotensin II type 1 receptor 1166A/C gene polymorphism and two polymorphisms of angiotensinogen, namely Met235Thr and Thr174Met, pointed at the culprit artery in patients with ST-segment elevation myocardial infarction (STEMI). The AGTR1 1166A/C polymorphism and two AGT gene polymorphisms, Met235Thr and Thr174Met, were assessed in 100 patients with STEMI. The odds ratio (OR) of circumflex artery (CRX) responsible for STEMI was 3.49 (95% CI: 1.1-10.8, p<0.05) for MetThr genotype for AGT Met235Thr gene and 4.54 (95% CI: 1.5-14.2, p<0.01) for ThrMet genotype for AGT Thr174Met gene. Homozygous ThrThr genotype for AGT Thr174Met gene reduced OR of CRX as culprit artery in STEMI (OR=0.29, 95% CI: 0.1-0.9, p<0.05). However, the highest OR that increased up to 13.71 (95% CI: 1.58-119.3) was shown in case of right coronary artery and C/C genotype for AGTR1 1166A/C gene. Polymorphism of AGTR1 1166A/C gene can point at the right coronary artery as infarct-related artery in STEMI. Polymorphisms of AGT Met235Thr and AGT Thr174Met genes are able to mark increased or reduced odds ratio of circumflex artery as culprit artery in STEMI.